StockNow
Calendar
Log in
Global Markets

DiaSorin (DIA IM) 9M 2026 (EUR): Revenue 910mln; Adj. EBITDA 297mln; Adj. EBIT 228mln; Adj. net income 159mln; Q3 revenue +8% at constant FX; 2026 guidance confirmed, including Adj. EBITDA margin 32-33%

ORIGINAL · NewsquawkDiaSorin (DIA IM) 9M 2026 (EUR): Revenue 910mln; Adj. EBITDA 297mln; Adj. EBIT 228mln; Adj. net income 159mln; Q3 revenue +8% at constant FX; 2026 guidance confirmed, including Adj. EBITDA margin 32-33%
StockNow breaking-news AI analysis

DiaSorin confirmed its 2026 guidance, including an adjusted EBITDA margin of 32–33%.

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
U.S. Markets

Nebius Group NV (NBIS) Q3 2026 (USD): Adj. EBITDA 465.8mln (exp. 351.8mln), Revenue 980.8mln (exp. 907.2mln)

NBISGeopolitics

US President Trump posts "We don’t need a deal with Iran. Those days have long since passed. We’ve got their money, Hundreds of Billions of Dollars, and we’ve got their Strait! Thank you for your attention to this matter."

U.S. Markets

Citrini's Jukan says that "One thing I’ve been able to confirm is that NVIDIA's (NVDA) Rubin has been delayed again. I’m told motherboard warpage caused the latest delay and that the HBM issue was resolved in October"

NVDA